CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jan. 31, 2021	Jul. 31, 2020
Current assets
Cash	$ 204,545	$ 18,281
Investment securities	42,608	10,436
Other prepaid expenses and current assets	4,540	2,945
Total current assets	251,693	31,662
Intellectual property	300	300
Project development costs, including $103,944 and $51,500 with related parties, at January 31, 2021 and July 31, 2020, respectively	3,046,634	134,413
Total assets	3,298,627	166,375
Current liabilities
Accounts payable and accrued expenses	145,325	170,972
Compensation and related expenses payable, including $285,000 and $90,000 to a related party at January 31, 2021 and July 31, 2020, respectively	322,370	120,317
Payable for rescinded stock subscription receivable	60,000
Unsecured promissory notes payable to related party, including accrued interest payable of $6,365 at January 31, 2021	866,365
Convertible promissory note payable, including accrued interest payable of $427, at July 31, 2020		25,427
Total current liabilities	1,394,060	316,716
Non-current liabilities:
Secured multiple advance promissory note payable to related party, including accrued interest payable of $27,444 at January 31, 2021	1,027,444
Convertible promissory note payable, net of discount on debt, including accrued interest payable of $1,877 at January 31, 2021	57,297
Total liabilities	2,478,801	316,716
Stockholders' deficiency:
Preferred Stock, $0.0001 par value; authorized - 20,000,000 shares; issued and outstanding - 1,434 shares ; Series B preferred stock, $0.0001 par value; authorized - 2,000,000 shares; issued and outstanding - 1,347 shares	202	202
Common stock, $0.0001 par value; authorized - 200,000,000 shares; issued and outstanding - 121,270,171 shares and 96,691,761 shares at January 31, 2021 and July 31, 2020, respectively	12,127	9,669
Additional paid-in capital	3,357,356	1,456,644
Common stock subscription receivable, related party	(482,600)	(550,000)
Accumulated deficit	(2,067,331)	(1,066,928)
Total stockholders’ equity (deficiency)	819,826	(150,341)
Total liabilities and members' equity	3,298,627	166,375
Series B Preferred Stock
Stockholders' deficiency:
Preferred Stock, $0.0001 par value; authorized - 20,000,000 shares; issued and outstanding - 1,434 shares ; Series B preferred stock, $0.0001 par value; authorized - 2,000,000 shares; issued and outstanding - 1,347 shares	$ 72	$ 72